AMPK promotes Arf6 activation in a kinase-independent manner upon energy deprivation
Abstract
AMP-activated protein kinase (AMPK) is a crucial cellular nutrient and energy sensor that maintains energy homeostasis. AMPK also governs cancer cell invasion and migration by regulating gene expression and activating multiple cellular signaling pathways. ADP-ribosylation factor 6 (Arf6) can be activated via nucleotide exchange by guanine nucleotide exchange factors (GEFs), and its activation also regulates tumor invasion and migration. By studying GEF-mediated Arf6 activation, we elucidated that AMPK functions as a noncanonical GEF for Arf6 in a kinase-independent manner. Moreover, by examining the physiological role of the AMPK-Arf6 axis, we determined that AMPK activates Arf6 upon glucose starvation and 5-aminoimidazole-4-carboxamide-1-{beta}-D-ribofuranoside (AICAR) treatment. We further identified the binding motif in the C-terminal regulatory domain of AMPK that is responsible for promoting Arf6 activation and thus inducing cell migration and invasion. These findings reveal a noncanonical role of AMPK in which its C-terminal regulatory domain serves as a GEF for Arf6 during energy deprivation.
02 /Specification & Classification
Click any tag to browse matching papers- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Spatial regulation of AMPK signaling revealed by a sensitive kinase activity reporter
Danielle L. Schmitt, Stephanie D. Curtis, … Jin Zhang·Nature CommunicationsPeer-reviewed·Jul 5, 2022
- Translational control of AMPK activity in melanoma
Natália Vadovičová, Anna Lešková, … Stjepan Uldrijan·Cell Communication and SignalingPeer-reviewed·Apr 28, 2026
- AMPK promotes induction of a tumor suppressor FLCN through activation of TFEB independently of mTOR
Caterina Collodet, Marc Foretz, … Kei Sakamoto·The FASEB JournalPeer-reviewed·Aug 12, 2019
- Midkine noncanonically suppresses AMPK activation through disrupting the LKB1-STRAD-Mo25 complex
T. Xia, D. Chen, … H.-l. Piao·bioRxiv·Sep 27, 2021
- Oncogenic Activation of AKT by MAPK6
- Tumor protein D52 (TPD52) affects cancer cell metabolism by negatively regulating AMPK.